TY - CHAP M1 - Book, Section TI - Nausea and Vomiting A1 - Gravatt, Leigh Anne Hylton A1 - Donohoe, Krista L. A1 - DiPiro, Cecily V. A2 - DiPiro, Joseph T. A2 - Talbert, Robert L. A2 - Yee, Gary C. A2 - Matzke, Gary R. A2 - Wells, Barbara G. A2 - Posey, L. Michael PY - 2017 T2 - Pharmacotherapy: A Pathophysiologic Approach, 10e AB - Patient Care Process for Nausea and VomitingCollectPatient characteristics (e.g., age, sex, pregnancy status, triggers)Patient medical history (personal and family), history of NVSocial history (e.g., tobacco/ethanol/cannabis use) and dietary habitsCurrent medications including: prescription, non-rescription, herbal products, dietary supplementsObjective data (e.g., QTc prolongation, BP/pulse, complete metabolic panel, CBC, liver function, weight, skin turgor, urine output)AssessDuration, frequency, severity of nausea and vomitingAbility/willingness to pay for treatment optionsEmotional status (e.g., presence of anxiety, depression)Assess ability of the patient to use oral, rectal, injectable, or transdermal medicationsSuccess of previous antiemetic regimensFor CINV: Assess emetic risk of chemotherapy (see Table 35-2)For PONV: Assess risk factors for developing PONV (see Table 35-5)Plan*Drug therapy regimen including specific antiemetic(s), dose, route, frequency, and duration (see Tables 35-3, 35-6)Monitoring parameters including efficacy (e.g., reduction in symptoms, resolution of laboratory test abnormalities, resumption of normal oral intake) and safety (e.g., QTc prolongation, drug-drug interactions); frequency and timing of follow-upPatient education (e.g., purpose of treatment, dietary and lifestyle modification, invasive procedures, drug-specific information, medication administration technique)Self-monitoring for resolution of symptoms, when to seek emergency medical attentionReferrals to other providers when appropriate (e.g., gastroenterologist, dietitian, OBGYN, oncologist, anesthesiologist)Implement*Provide patient education regarding all elements of treatment planUse motivational interviewing and coaching strategies to maximize adherenceSchedule follow-up, adherence assessmentFollow-up: Monitor and EvaluateResolution of nausea and vomiting symptomsEvaluate need for rescue antiemeticsPresence of adverse effectsPatient adherence to treatment plan*Collaborate with patient, caregivers, and other health professionals SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1154960474 ER -